SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Don Miller who wrote (2523)4/23/1999 1:04:00 AM
From: Bob Swift  Read Replies (1) of 10280
 
Without detailed data from SEPR, it is next to impossible for an outsider to accurately value SEPR. Even for SEPR, until they have enough clinical data, some of their hundreds of patents may or may not pan out. Thus, it is very difficult for anyone to come to an agreement of what SEPR should be valued at at this moment.How will JNJ or whoever and SEPR negotiate, if at all ? We are just seeing the first vein of gold, how many ounces there are is anyone's guess. A buyout at this stage, if it happens, would represent poor judgement on both the buyer and the seller.
Lets get back to the serious business of praying for recovery. We have enough of buying dips !
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext